Shear stress, SIRT1, and Arterial Stiffening
剪切应力、SIRT1 和动脉硬化
基本信息
- 批准号:8484429
- 负责人:
- 金额:$ 9.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-20 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAblationAffectAgeAgingAging-Related ProcessArteriesAttenuatedBiological AvailabilityBlood VesselsBlood flowCa(2+)-Calmodulin Dependent Protein KinaseCalcium/calmodulin-dependent protein kinaseCardiovascular DiseasesCellsCellular Stress ResponseClinicalClinical ResearchCoculture TechniquesCollagenCoronary heart diseaseElasticityElastinEndothelial CellsEndotheliumEtiologyEventExhibitsExtracellular MatrixGene ExpressionHeart DiseasesHistone DeacetylaseHomologous GeneHypertrophyImpairmentKnock-outKnockout MiceLeft Ventricular HypertrophyLongevityMammalian CellMammalsMating TypesMeasuresMechanicsMolecularMolecular ProfilingMusNitric OxideOxidative StressPathway interactionsPeroxisome Proliferator-Activated ReceptorsPhenotypePhosphorylationPhosphotransferasesPhysiologic pulsePreventionPropertyPulsatile FlowPulse PressureReactive Oxygen SpeciesRegulationResearchRisk FactorsRoleSignal TransductionSmooth Muscle MyocytesStimulusStrokeSystemTestingTransgenic MiceVascular Endothelial CellVasodilationYeastsage relatedanti agingbasebiological adaptation to stresscardiovascular risk factorgain of functionhemodynamicshuman NOS3 proteinin vivomouse modelnoveloverexpressionoxidationpublic health relevanceresearch studyresponseshear stressspatiotemporal
项目摘要
DESCRIPTION (provided by applicant): Arterial stiffening, manifested by thickening and reduced elasticity of conduit arteries, is an independent risk factor for stroke and heart disease. Although the etiology of arterial stiffening correlates well with aging, the underlying cellular and molecular basis remains unclear. In vivo, hemodynamic forces dynamically act on the vascular wall, which greatly affect arterial function and mechanical properties. Arterial stiffening may involves aberrant endothelial response to shear stress resulted from these hemodynamic forces. We recently found that SIRT1, an anti-aging regulator is modulated by shear stress in vascular endothelial cells (ECs). Moreover, calmodulin-dependent protein kinase (CaMKK) appears to be a shear stress-sensitive kinase that regulates SIRT1. We thus hypothesize that shear stress upregulates SIRT1 in the endothelium of conduit arteries, which ameliorates pathophysiological remodeling leading to arterial stiffening. At the upstream, CaMKKb is activated in response to the physiologically relevant shear stress. As a consequence of the activated CaMKKb-SIRT1 pathway, the endothelial nitric oxide synthase (eNOS)-derived NO bioavailability and PGC-1a-regulated ROS scavenger expression are augmented. Thus, the advantageous effects of shear stress-augmented SIRT1 include decreased oxidative stress and remodeling of extracellular matrices. To test our hypothesis, three Specific Aims are proposed. Specific Aim 1 will examine the hemodynamic factors critical for the induction of SIRT1 in cultured ECs. Molecular signaling experiments will then be conducted to study the mechanism by which CaMKKb regulates SIRT1 in ECs responding to the defined shear stress. Specific Aim 2 will elucidate the cellular and molecular mechanisms by which shear stress-induced SIRT1 exerts anti- stiffening effects in an EC/vascular smooth muscle cell co-culture system. We will decipher the synergistic effect of SIRT1 and AMP-activated protein kinase (AMPK) in eNOS-derived NO bioavailability and PGC-1a-regulated reactive oxygen species (ROS) scavengers. Specific Aim 3 will investigate the role of shear stress-activated SIRT1 in arterial stiffening in mouse models. Specifically, we will compare the spatiotemporal changes of arterial stiffening in EC-sirt1-/- knockout, Tg-EC-sirt1, and CaMKKb-/- mice. The arterial stiffening-associated changes in hemodynamic factors, aortic wall remodeling, and gene expression profiles will be measured and correlated. Results from these proposed studies, if as anticipated, will help to understand the mechano and molecular basis of arterial stiffening.
描述(由申请人提供):动脉硬化,表现为导管动脉增厚和弹性降低,是中风和心脏病的独立风险因素。虽然动脉硬化的病因与衰老密切相关,但其潜在的细胞和分子基础仍不清楚。在体内,血液动力学力动态地作用于血管壁,这极大地影响动脉功能和机械特性。动脉硬化可能涉及内皮对这些血流动力学力引起的剪切应力的异常反应。我们最近发现,SIRT 1,一种抗衰老的调节因子,在血管内皮细胞(ECs)中受到剪切应力的调节。此外,钙调蛋白依赖性蛋白激酶(CaMKK)似乎是一种剪切应力敏感的激酶,调节SIRT 1。因此,我们假设,剪切应力上调SIRT 1在血管内皮细胞,从而改善病理生理重塑导致动脉硬化。在上游,CaMKKb响应于生理相关的剪切应力而被激活。由于激活的CaMKKb-SIRT 1途径,内皮型一氧化氮合酶(eNOS)衍生的NO生物利用度和PGC-1a调节的ROS清除剂表达增加。因此,切应力增强的SIRT 1的有利作用包括减少氧化应激和细胞外基质的重塑。为了验证我们的假设,提出了三个具体目标。具体目标1将检查在培养的EC中诱导SIRT 1的关键血流动力学因素。然后进行分子信号传导实验以研究CaMKKb调节内皮细胞中SIRT 1对所定义的切应力的响应的机制。具体目标2将阐明剪切应力诱导的SIRT 1在EC/血管平滑肌细胞共培养系统中发挥抗硬化作用的细胞和分子机制。我们将解读SIRT 1和AMP活化蛋白激酶(AMPK)在eNOS衍生的NO生物利用度和PGC-1a调节的活性氧(ROS)清除剂中的协同作用。具体目标3将研究剪切应力激活的SIRT 1在小鼠模型动脉硬化中的作用。具体而言,我们将比较EC-sirt 1-/-敲除、Tg-EC-sirt 1和CaMKKb-/-小鼠动脉硬化的时空变化。将测量血流动力学因素、主动脉壁重塑和基因表达谱的动脉硬化相关变化并进行关联。这些研究的结果,如果如预期的那样,将有助于了解动脉硬化的机械和分子基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John YJ Shyy其他文献
John YJ Shyy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John YJ Shyy', 18)}}的其他基金
AMPK Regulation of ACE2 in Endothelial Health and Disease
AMPK 在内皮健康和疾病中对 ACE2 的调节
- 批准号:
10568995 - 财政年份:2022
- 资助金额:
$ 9.93万 - 项目类别:
AMPK Regulation of ACE2 in Endothelial Health and Disease
AMPK 在内皮健康和疾病中对 ACE2 的调节
- 批准号:
10391055 - 财政年份:2022
- 资助金额:
$ 9.93万 - 项目类别:
Flow-Induced Endothelial Innate Immunity and Atherosclerosis Susceptibility
血流诱导的内皮先天免疫和动脉粥样硬化易感性
- 批准号:
9751360 - 财政年份:2016
- 资助金额:
$ 9.93万 - 项目类别:
Flow-Induced Endothelial Innate Immunity and Atherosclerosis Susceptibility
血流诱导的内皮先天免疫和动脉粥样硬化易感性
- 批准号:
9185542 - 财政年份:2016
- 资助金额:
$ 9.93万 - 项目类别:
The miRNA-mediated Translational De-suppression in Hypoxic Endothelium
缺氧内皮细胞中 miRNA 介导的翻译去抑制
- 批准号:
8534808 - 财政年份:2012
- 资助金额:
$ 9.93万 - 项目类别:
The miRNA-mediated Translational De-suppression in Hypoxic Endothelium
缺氧内皮细胞中 miRNA 介导的翻译去抑制
- 批准号:
8716847 - 财政年份:2012
- 资助金额:
$ 9.93万 - 项目类别:
相似海外基金
Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
- 批准号:
2867610 - 财政年份:2023
- 资助金额:
$ 9.93万 - 项目类别:
Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
- 批准号:
BB/W009633/1 - 财政年份:2022
- 资助金额:
$ 9.93万 - 项目类别:
Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2021
- 资助金额:
$ 9.93万 - 项目类别:
Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
- 批准号:
459043 - 财政年份:2021
- 资助金额:
$ 9.93万 - 项目类别:
Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2020
- 资助金额:
$ 9.93万 - 项目类别:
Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10561642 - 财政年份:2019
- 资助金额:
$ 9.93万 - 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2019
- 资助金额:
$ 9.93万 - 项目类别:
Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
- 批准号:
2243045 - 财政年份:2019
- 资助金额:
$ 9.93万 - 项目类别:
Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10359032 - 财政年份:2019
- 资助金额:
$ 9.93万 - 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
- 批准号:
428988 - 财政年份:2019
- 资助金额:
$ 9.93万 - 项目类别:
Studentship Programs